Endocrinology
News
FDA approves orphan drug evinacumab-dgnb for homozygous FH
Indicated for homozygous familial hypercholesterolemia on top of other lipid-modifying therapy, Evkeeza (Regeneron) is a first-in-class inhibitor...
From the Journals
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
From the Journals
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
From the Journals
Temper enthusiasm for long-term treatment with bisphosphonates?
A real-world study of nearly 30,000 women shows no benefit, in terms of hip fracture risk, between taking oral bisphosphonates for 10 years vs. 5...
From the Journals
Sac/val heart failure benefit extends to diabetes patients
Sacubitril/valsartan had a similar effect on reverse cardiac remodeling for heart failure and reduced ejection fraction regardless of diabetes...
News
FDA approves liraglutide for adolescents with obesity
From the Journals
To D or not to D? Vitamin D doesn’t reduce falls in older adults
A study of wide-ranging vitamin D dosing finds no reduction in risk of falls, while high doses may even increase risk. But editorialist says check...
From the Journals
Diabetic retinopathy may predict greater risk of COVID-19 severity
“Our study reports the first description of diabetic retinopathy as a potential risk factor for poor COVID-19 outcomes,” said the authors of a new...
Feature
Noninvasive, low-cost CGM for type 2 diabetes coming in U.S. and EU
Neumara Medical’s SugarBEAT device plus digital coaching aims to reverse, or at least better manage, type 2 diabetes and should be available soon...
From the Journals
New AHA scientific statement on menopause and CVD risk
An AHA scientific statement aims to raise awareness of healthcare providers and women about the menopause transition as a time of increasing heart...
From the Journals
Blood glucose on admission predicts COVID-19 severity in all
Those with abnormally high glucose levels were more than twice as likely to die from the virus than were those with normal readings.